Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02314858 · ClinicalTrials.gov registry record · NA
Tailored Treatment to Enhance Risk Perception in Sleep Apnea
A NA study, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 284
- Enrollment target
NCT02314858 is a NA study that has completed, run by National Jewish Health. The registered enrollment target is 284 participants.
The verdict
NCT02314858, a NA study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
Study Summary
Obstructive Sleep Apnea (OSA) is seen in approximately 6% of Americans. It is a serious medical condition with significant medical and psychological consequences, including diabetes, hypertension, and cardiovascular disease. The treatment of choice for OSA is Positive Airway Pressure therapy (PAP). PAP supplies positive pressure to the upper airway creating a "pneumatic splint" to keep the airway open during sleep. Adherence to PAP is notoriously low, with as few as 50% reaching minimal guidelines for adherence. One comprehensive review of adherence research found that adherence to PAP was less than that for any other medical disorder. The problem of adherence is significant not only because of the medical consequences that can ensue, but also because third party payers have begun to refuse to pay for PAP therapy when adherence is less than optimal, even in the face of clinical improvement. This is a critical time to address this problem. This research study is designed to identify methods that may help people respond to PAP, the most common therapy for OSA. Identifying these methods may be an important way to better care for patients with obstructive sleep apnea. With this research, the investigators hope to find ways to help people have a better response to treatment and a better quality of life.
Interventions
- BEHAVIORAL Treatment as Usual (TAU)
- BEHAVIORAL Brief Personalized Video (BPV)
- BEHAVIORAL Non-Personalized Video (NPV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2021-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02314858
The ClinicalTrials.gov registry entry for NCT02314858 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT02314858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02314858 about?
NCT02314858 is a clinical study titled "Tailored Treatment to Enhance Risk Perception in Sleep Apnea". Obstructive Sleep Apnea (OSA) is seen in approximately 6% of Americans. It is a serious medical condition with significant medical and psychological consequences, including diabetes, hypertension, and cardiovascular disease. The treatment of choice for OSA is Positive Airway Pressure therapy (PAP). ...
What is the current status of trial NCT02314858?
This trial is currently completed. It is a NA study. The enrollment target is 284 participants. The study started on 2014-10-01. Estimated completion is 2021-03.
What interventions are being tested in trial NCT02314858?
The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Brief Personalized Video (BPV) (BEHAVIORAL), Non-Personalized Video (NPV) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02314858?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.